HIG:NYSEThe Hartford Insurance Group, Inc. Analysis
Data as of 2026-05-21 - not real-time
$136.69
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The Hartford (HIG) is trading at $136.69, comfortably above its 20‑day ($134.96), 50‑day ($135.61) and 200‑day ($133.99) moving averages, indicating short‑term momentum support. The stock’s RSI of 54 and a bullish MACD histogram (+0.32) suggest neutral to mildly positive technical bias, while volatility over the past 30 days sits near 20%, higher than typical for the insurance sector. Fundamentally, HIG trades at a trailing P/E of 9.6 versus an industry average of 16.7, positioning it as a clear value play, and its forward P/E of 9.5 reinforces this discount. The company posted 6.1% revenue growth YoY, a solid profit margin of 14.1% and an impressive ROE of 22.7%, underscoring strong profitability. Cash flow remains robust with $5.98 B operating cash flow and a low payout ratio of 15.8%, supporting the 1.76% dividend yield and suggesting dividend sustainability. However, Q1 2026 non‑GAAP earnings of $3.09 per share missed consensus by 8.8%, introducing a near‑term earnings‑miss risk. Analyst consensus remains bullish (Buy) with a median price target of $149, implying roughly 9% upside, and the Fear & Greed Index’s “Extreme Greed” stance reflects heightened market optimism.
Given a low beta of 0.27, modest debt levels and a stable liquidity profile, HIG presents a defensively positioned investment with attractive valuation metrics. The modest upside, strong cash generation, and sustainable dividend make it a compelling addition for medium‑ to long‑term portfolios, while the recent earnings miss tempers short‑term expectations.
Given a low beta of 0.27, modest debt levels and a stable liquidity profile, HIG presents a defensively positioned investment with attractive valuation metrics. The modest upside, strong cash generation, and sustainable dividend make it a compelling addition for medium‑ to long‑term portfolios, while the recent earnings miss tempers short‑term expectations.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Q1 earnings miss versus consensus
- Technical price near support at $131.08
- Stable dividend yield of 1.76%
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued P/E relative to industry
- Strong ROE and revenue growth
- Attractive upside to analyst target price
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Durable insurance franchise with low beta
- Consistent cash flow supporting dividend sustainability
- Long‑term value upside and defensive sector positioning
Key Metrics & Analysis
Financial Health
Revenue Growth6.10%
Profit Margin14.11%
P/E Ratio9.6
ROE22.74%
ROA3.88%
Debt/Equity23.15
P/B Ratio2.0
Op. Cash Flow$6.0B
Free Cash Flow$5.6B
Industry P/E16.7
Technical Analysis
TrendNeutral
RSI54.1
Support$131.08
Resistance$140.11
MA 20$134.96
MA 50$135.61
MA 200$133.99
MACDBullish
VolumeStable
Fear & Greed Index90.55
Valuation
Fair Value$340.36
Target Price$149.45
Upside/Downside9.33%
GradeUndervalued
TypeBlend
Dividend Yield1.76%
Risk Assessment
Beta0.27
Volatility19.97%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.